Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AVECHO BIOTECHNOLOGY LIMITED Capital/Financing Update 2017

Oct 2, 2017

64468_rns_2017-10-02_b4b493b6-3968-4edb-80a0-8bf88ad6637d.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [232 x 41] intentionally omitted <==

ASX Limited Market Announcements Office

3 October 2017

Despatch of Information Booklet and Entitlement & Acceptance Form

Phosphagenics Limited (“ Company ” or “ Phosphagenics ”) advises that the Entitlement Offer Information Booklet and personalised Entitlement & Acceptance Form relating to its non-renounceable pro-rata entitlement offer announced on 26 September 2017 (“Entitlement Offer”) has today been despatched to eligible shareholders.

Eligible shareholders who have elected to receive notifications electronically will be issued the Entitlement Offer Information Booklet by email. The documents will be issued to all other eligible shareholders by post.

Eligible shareholders should read the Entitlement Offer Information Booklet for further details on the Entitlement Offer. Applications and payment under the Entitlement Offer must be received by 5.00 pm (AEST) on Thursday, 12 October 2017.

For further information regarding the Entitlement Offer, please contact Phosphagenics on 03 9002 5000 between 9.00 am to 5.00 pm (AEST) Monday to Friday during the offer period. Alternatively, contact your stockbroker, solicitor, accountant or other professional adviser.

Phosphagenics Limited ACN 056 482 403 ABN 32 056 482 403

Unit A8, 2A Westall Road, Clayton VIC 3168 Australia Tel: +61 (0)3 9002 5000 www.phosphagenics.com Email: [email protected]